Reactivation of the embryonic ζ-globin gene ameliorates severe forms of α-thalassemia.

Reactivating the silenced embryonic ζ-globin gene in mice and human cells can produce therapeutic levels of α-like globin, rescuing severe α-thalassemia conditions.

• Why it matters: Severe α-thalassemia forms like HbH disease and BHFS require lifelong transfusions or transplants, highlighting the need for novel treatments that address the underlying genetic causes.
• What they did: Researchers identified cis-regulatory elements responsible for ζ-globin silencing and developed gene-editing strategies to reactivate ζ-globin expression, tested in a mouse model and patient-derived cells.
• The result: The approach rescued prenatal lethality in mice and reactivated ζ-globin to levels exceeding those in mice, suggesting potential for effective therapy in severe human α-thalassemia cases.